
ABOUT PAREXEL INTERNATIONAL
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best quality solutions to make every phase of the clinical trial process more efficient.
​With the people, insight and focus on operational excellence, we work With Heart™ every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. This approach continues to earn us recognition industrywide, with Parexel being named “Best Contract Research Organization” in November 2023 by an independent panel for Citeline, “Top CRO to Work With” by investigative sites worldwide in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey and recipient of the 2023 Society for Clinical Research Sites (SCRS) Eagle Award for advancing the clinical research profession through strong site partnerships. For more information, visit us at www.parexel.com.
INDUSTRY INSIGHTS
-
Expand The Use And Value Of Your Product Over Time
This discussion explores a forward-thinking approach that encourages biotech companies to look beyond initial approval, exploring new indications, markets, and patient populations.
-
Implement Market Launch Strategy, Pre-Approval
By focusing on proactive planning and risk mitigation, this episode offers biotech leaders actionable insights to optimize their pre-launch strategies, setting the stage for a strong market debut and sustained commercial success.
-
Plan How To Get To Market Quickly, Post Proof-Of-Concept
This episode of the De-risking Drug Development series focuses on accelerating drug development and enhancing product differentiation through innovative trial design.
-
Focus On Safety And Efficacy And Prove Quickly That Your Product Works
Examine essential decisions for the early phases of the development process where safety, tolerability, and efficacy play critical roles in determining a drug’s success.
-
Challenges And Best Practices For Developing ADCs
Through this workshop, participants will gain insights into the development and evaluation of ADCs, from preclinical research to manufacturing intricacies (CMC) and clinical advancements.
-
The Potential Of Neoadjuvant Therapy In The Treatment Of Solid Tumors
Neoadjuvant therapy, integrating chemotherapy and immunotherapy, shows promise in treating NSCLC and other cancers, improving outcomes, enabling earlier resection.
-
Improving Protocol Design With An Early Think-Tank Initiative
Explore how a client's first-in-human trial for a cancer drug was improved by using a think-tank approach and gap analysis, accelerating protocol design and streamlining development.
-
Accelerate Cell And Gene Therapy Trials With Targeted Site Selection
Despite the inherent complexity and resource demands of CAGT trials, there is a large push by community-based, non-academic hospitals and clinics to strategically complete multiple studies.
-
Parexel Introduces FDA Expedited Designation Trends For Advanced Therapies
The trend for advanced therapies seeking regulatory designations is shifting to favor RMAT and FT, which offer a more accessible alternative compared to the stringent BTD.
-
Supporting A One-Time Gene Therapy With A Population PD Model
How was predictive population PD modeling used to help a gene therapy for beta-thalassemia achieve FDA approval?
-
3 Strategies For Articulating A Coherent Product Value Story
These strategies are designed to help you navigate the intricate landscape of product development, ensuring that your innovation not only reaches the market but also achieves sustainable success in a competitive environment.
-
Are You Ready For The Coming Wave Of Regulatory Compliance?
The COVID-19 pandemic exposed critical vulnerabilities in medical product supply chains, highlighting the need for robust regulatory compliance. Prepare your facility for future regulatory scrutiny by strengthening your compliance and quality management practices.
-
Lessons From China And The United States On The Use Of RWE In Regulatory Submissions
Read along as authors share their most significant lessons, offering guidance on how to harness the full potential of RWE to drive innovation and efficiency in drug development.
-
Are You Using Real-World Evidence?
This series of case studies illustrates how Real-World Evidence (RWE) can significantly enhance decision-making processes, leading to more efficient development strategies that save both time and costs.
-
Oncology Trials: Why The Patient Perspective Is Essential To Success
By adopting a patient-guided approach, sponsors and CROs can focus on achieving outcomes that resonate most with the patients they aim to help, ensuring that the therapies developed are both effective and meaningful.
CONTACT INFORMATION
Parexel International
2520 Meridian Parkway
Durham, NC 27713, NC 27713
UNITED STATES
Contact: Mark Eberhardt